Community Oncology Connections™: Monotherapies vs Combinations – Navigating Oral SERDs and Targeted Combination Strategies in HR+/HER2- Metastatic Breast Cancer
Thursday, July 9, 2026
5:45 PM - 6:45 PM CT
This program brings together expert faculty to discuss the latest advances and enable the integration of oral SERDs and emerging combination strategies into HR+/HER2- metastatic breast cancer care.

